Breaking News Instant updates and real-time market news.

2021-02-22 07:27:27 EOLS Evolus $12.27 / +5.09 (+70.89%) 07:27 02/22/21 02/22 07:27 02/22/21 07:27	Evolus price target raised to $8 from $4 at Barclays Barclays analyst Balaji Prasad raised the firm's price target on Evolus to $8 from $4 and keeps an Underweight rating on the shares. The analyst sees the ITC settlement news as a positive for Evolus, with litigations being dismissed in exchange for royalties and equity, "removing a key overhang that has plagued the stock for some time."
EOLS Evolus $12.27 / +5.09 (+70.89%) 02/22/21 Cantor Fitzgerald Evolus price target raised to $20 from $11 at Cantor Fitzgerald 02/22/21 Mizuho Evolus price target raised to $9 from $5 at Mizuho 02/22/21 H.C. Wainwright Evolus price target raised to $18 from $6 at H.C. Wainwright 02/19/21 Stifel Stifel raises Evolus price target to $25, calls settlement a 'win for all'

2021-02-22 07:27:27

EOLS

Evolus

$12.27 / +5.09 (+70.89%)

07:27

02/22/21

02/22

07:27

02/22/21

07:27

Evolus price target raised to $8 from $4 at Barclays

Barclays analyst Balaji Prasad raised the firm's price target on Evolus to $8 from $4 and keeps an Underweight rating on the shares. The analyst sees the ITC settlement news as a positive for Evolus, with litigations being dismissed in exchange for royalties and equity, "removing a key overhang that has plagued the stock for some time."

EOLS Evolus

$12.27 / +5.09 (+70.89%)

02/22/21 Cantor Fitzgerald: Evolus price target raised to $20 from $11 at Cantor Fitzgerald

02/22/21 Mizuho: Evolus price target raised to $9 from $5 at Mizuho

02/22/21 H.C. Wainwright: Evolus price target raised to $18 from $6 at H.C. Wainwright

02/19/21 Stifel: Stifel raises Evolus price target to $25, calls settlement a 'win for all'

TODAY'S FREE FLY STORIES

On The Fly	Fly Intel: Wall Street's top stories at midday » 12:25 03/02/21 03/02 12:25 03/02/21 12:25 TGT Target $177.29 / -8.83 (-4.74%) , KSS Kohl's $58.35 / +1.4 (+2.46%) , JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) , MRK Merck $73.20 / +0.83 (+1.15%) , ZM Zoom Video $401.54 / -8.125 (-1.98%) , PERI Perion Network $27.00 / +5.495 (+25.55%) , AMRS Amyris $20.46 / +4.84 (+30.99%) , MORF Morphic $73.25 / -11.56 (-13.63%) , FGEN FibroGen $35.50 / -14.76 (-29.37%) , NVAX Novavax $201.33 / -39 (-16.23%) Equity futures were… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TGT KSS JNJ MRK ZM PERI AMRS MORF FGEN NVAX TGT Target $177.29 / -8.83 (-4.74%) 10:55 Today Target 'off to a strong start' in February, with comps up 20% 09:57 Today Target says testing new sortation center to expedite online orders 09:16 Today Target says 'our business model is working as intended' 08:52 Today Target not providing FY21 guidance 'in the face of continued uncertainty' KSS Kohl's $58.35 / +1.4 (+2.46%) 09:29 Today Kohl's planning $200M-$300M in share repurchases in 2021 09:18 Today Kohl's plans to refresh approximately 675 stores over the next two years 09:03 Today Kohl's 'optimistic that brighter days are ahead' 08:56 Today Kohl's 'confident' in ability to expand operating margin to 7%-8% by 2023 JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA MRK Merck $73.20 / +0.83 (+1.15%) 03/01/21 Merck announces voluntary withdrawal for KEYTRUDA in SCLC 03/01/21 Merck: FDA accepts gefapixant New Drug Application for review 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash 02/25/21 Merck, Pandion Therapeutics deal has approx. total equity value of $1.85B ZM Zoom Video $401.54 / -8.125 (-1.98%) 03/01/21 Zoom Video jumps 8% to $444.10 after Q4 results, FY22 guidance beat estimates 03/01/21 Lumen announces launch of Zoom Phone 02/03/21 Zoom Video announces availability of Zoom Rooms innovations 01/26/21 User reports indicate Zoom Video experiencing issues, says DownDetector PERI Perion Network $27.00 / +5.495 (+25.55%) 01/19/21 Perion Network trading halted, news pending 12/07/20 Perion Network jumps 8% to $8.37 after raising Q4, FY20 guidance 11/02/20 Perion Network, Microsoft renew strategic partnership for four more years AMRS Amyris $20.46 / +4.84 (+30.99%) 03/01/21 Amyris to acquire Costa Brazil brand, terms not disclosed 02/24/21 Amyris launches Pipette clean baby care brand in Target 02/22/21 Amyris announces pre-clinical results for COVID RNA vaccine platform 02/02/21 Amyris announces results from clinical study of clean topical formulation MORF Morphic $73.25 / -11.56 (-13.63%) 03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen FGEN FibroGen $35.50 / -14.76 (-29.37%) 03/01/21 FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA 12/22/20 FibroGen doses first patient in ZEPHYRUS-2 Phase 3 study of pamrevlumab 12/19/20 AstraZeneca updates on U.S. regulatory review of roxadustat 12/18/20 FibroGen says FDA extends review period for roxadustat NDA NVAX Novavax $201.33 / -39 (-16.23%) 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/22/21 Novavax completes enrollment of PREVENT-19 Phase 3 trial TGT KSS JNJ MRK ZM PERI AMRS MORF FGEN NVAX TGT Target $177.29 / -8.83 (-4.74%) 02/09/21 Jefferies Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Stifel Target upgraded to Buy from Hold at Stifel 01/14/21 DA Davidson Target price target raised to $229 from $208 at DA Davidson KSS Kohl's $58.35 / +1.4 (+2.46%) 02/18/21 Morgan Stanley Kohl's price target raised to $40 from $27 at Morgan Stanley 02/05/21 Baird Kohl's price target raised to $58 from $48 at Baird 02/05/21 Deutsche Bank Kohl's price target raised to $55 from $51 at Deutsche Bank 02/03/21 Fly Intel: Top five analyst upgrades JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MRK Merck $73.20 / +0.83 (+1.15%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush ZM Zoom Video $401.54 / -8.125 (-1.98%) 09:56 Today Fly Intel: Top five analyst upgrades 07:15 Today Morgan Stanley Zoom Video price target raised to $420 from $390 at Morgan Stanley 06:07 Today Piper Sandler Zoom Video upgraded to Overweight from Neutral at Piper Sandler 01/26/21 MKM Partners Fiverr downgraded to Sell from Neutral at MKM Partners PERI Perion Network $27.00 / +5.495 (+25.55%) 02/10/21 Lake Street Perion Network price target raised to $30 from $18 at Lake Street 02/10/21 Roth Capital Perion Network price target raised to $30 from $16 at Roth Capital 01/04/21 Lake Street Perion Network price target raised to $18 from $12 at Lake Street 12/31/20 Sidoti Perion Network price target raised to $14 from $12 at Sidoti AMRS Amyris $20.46 / +4.84 (+30.99%) 02/26/21 Fly Intel: Top five analyst initiations 02/26/21 Roth Capital Amyris initiated with a Buy at Roth Capital 01/06/21 Cowen Amyris upgraded to Outperform with $9 price target at Cowen 01/06/21 Cowen Amyris upgraded to Outperform from Market Perform at Cowen MORF Morphic $73.25 / -11.56 (-13.63%) 03/01/21 Wells Fargo Morphic Holding price target raised to $103 from $40 at Wells Fargo 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 08/11/20 BMO Capital Morphic Holding price target raised to $37 from $30 at BMO Capital FGEN FibroGen $35.50 / -14.76 (-29.37%) 09:56 Today Fly Intel: Top five analyst downgrades 08:21 Today Jefferies FibroGen downgraded to Hold at Jefferies on increased risk for roxadustat 06:24 Today Citi FibroGen selloff on FDA panel a buying opportunity, says Citi 04:47 Today Jefferies FibroGen downgraded to Hold from Buy at Jefferies NVAX Novavax $201.33 / -39 (-16.23%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/22/21 Cantor Fitzgerald Cantor says PREVENT-19 gives Novavax potential for differentiated analyses 02/22/21 B. Riley Securities B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up 02/18/21 B. Riley Securities Novavax price target raised to $397 from $334 at B. Riley Securities TGT KSS JNJ MRK ZM PERI AMRS MORF FGEN NVAX TGT Target $177.29 / -8.83 (-4.74%) 06:34 Today Target reports Q4 adjusted EPS $2.67, consensus $2.54 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 11/18/20 Target reports Q3 total revenue $22.63B, consensus $20.93B KSS Kohl's $58.35 / +1.4 (+2.46%) 07:09 Today Kohl's sees FY21 EPS $2.45-$2.95, consensus ($2.43) 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 02/04/21 Kohl's reports preliminary Q4 EPS $1.00-$1.05, consensus 70c JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MRK Merck $73.20 / +0.83 (+1.15%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open ZM Zoom Video $401.54 / -8.125 (-1.98%) 03/01/21 Zoom Video sees FY22 EPS $3.59-$3.65, consensus $2.96 03/01/21 Zoom Video sees Q1 EPS 95c-97c, consensus 72c 03/01/21 Zoom Video reports Q4 EPS $1.22, consensus 79c 03/01/21 Notable companies reporting after market close PERI Perion Network $27.00 / +5.495 (+25.55%) 06:04 Today Perion Network raises FY21 revenue view to $370M-$380M from $350-$370 02/09/21 Perion Network sees FY21 revenue $350M-$370M, consensus $353.3M 02/09/21 Perion Network reports Q4 adjusted EPS 45c, consensus 18c 01/19/21 Perion Network sees Q4 EPS 35c-36, consensus 23c AMRS Amyris $20.46 / +4.84 (+30.99%) 08:34 Today Amyris sees FY21 revenue $400M, consensus $231.77M 08:32 Today Amyris reports Q4 adjusted EPS (3c), consensus (9c) MORF Morphic $73.25 / -11.56 (-13.63%) 03/01/21 Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) FGEN FibroGen $35.50 / -14.76 (-29.37%) 03/01/21 FibroGen reports Q4 EPS (64c), consensus (24c) 11/05/20 FibroGen reports Q3 EPS 35c, consensus (80c) NVAX Novavax $201.33 / -39 (-16.23%) 03/01/21 Novavax reports Q4 EPS ($2.70), consensus ($1.49) 11/09/20 Novavax reports Q3 EPS ($3.21), may not compare to consensus $1.73 03 Mar 20 Jan 13 Jan TGT KSS JNJ MRK ZM NVAX TGT Target $177.29 / -8.83 (-4.74%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/06/20 Chick-fil-A sues Tyson, others for poultry price-fixing, Bloomberg says 11/14/20 Targe booming during pandemic, stock still undervalued, Barron's says 10/24/20 Sprouts Farmers ready for rebound, Barron's says KSS Kohl's $58.35 / +1.4 (+2.46%) 02/22/21 Kohl's 'rejects' activist investor group attempt in statement to CNBC 02/21/21 Nine directors nominated to Kohl's board by activist investors, WSJ reports 09/21/20 Walmart to launch private label for men's and women's clothing, CNBC reports JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 08:03 Today Merck to help produce J&J Covid vaccine, Washington Post reports 06:20 Today Johnson & Johnson Covid-19 vaccine shipments begin rollout, WSJ reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports MRK Merck $73.20 / +0.83 (+1.15%) 08:03 Today Merck to help produce J&J Covid vaccine, Washington Post reports 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says ZM Zoom Video $401.54 / -8.125 (-1.98%) 12/23/20 Zoom Video developing web email service, Information reports 11/13/20 NYC mayor warns parents to plan for school shutdown, Bloomberg reports 11/10/20 Microsoft wants to demolish video-conferencing competition, BI reports 10/14/20 Zoom's Yuan says won't develop chat service to rival Slack, Bloomberg reports NVAX Novavax $201.33 / -39 (-16.23%) 02/11/21 EU official tells Reuters Novavax vaccine deal is close 01/29/21 Novavax expects to make 150M vaccine doses per month by May/June, Reuters says 01/11/21 EU close to 200M dose deal with Novavax, Moderna talks ongoing, Reuters reports 11/04/20 Novovax, Pfizer secure vaccine agreements with Australia, SMH reports TGT KSS JNJ MRK ZM PERI AMRS MORF FGEN NVAX TGT Target $177.29 / -8.83 (-4.74%) 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Target, Estee Lauder upgrades among today's top calls on Wall Street 01/13/21 Fly Intel: Wall Street's top stories for Wednesday KSS Kohl's $58.35 / +1.4 (+2.46%) 09:00 Today Fly Intel: Pre-market Movers 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday MRK Merck $73.20 / +0.83 (+1.15%) 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Pre-market Movers 02/04/21 Fly Intel: Wall Street's top stories for Thursday ZM Zoom Video $401.54 / -8.125 (-1.98%) 09:35 Today Zoom Video, TripAdvisor upgrades among today's top calls 09:00 Today Fly Intel: Pre-market Movers 03/01/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: What to watch in Zoom Video earnings report PERI Perion Network $27.00 / +5.495 (+25.55%) 01/19/21 Fly Intel: After-Hours Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday 12/07/20 Fly Intel: Pre-market Movers 10/07/20 Fly Intel: Pre-market Movers AMRS Amyris $20.46 / +4.84 (+30.99%) 09/15/20 Fly Intel: Wall Street's top stories for Tuesday 09/15/20 Fly Intel: Wall Street's top stories at midday 09/11/20 Fly Intel: Wall Street's top stories for Friday 09/11/20 Fly Intel: Wall Street's top stories at midday MORF Morphic $73.25 / -11.56 (-13.63%) 09:00 Today Fly Intel: Pre-market Movers 03/01/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday FGEN FibroGen $35.50 / -14.76 (-29.37%) 03/01/21 Fly Intel: After-Hours Movers 12/21/20 Fly Intel: Wall Street's top stories for Monday 12/21/20 Fly Intel: Wall Street's top stories at midday 12/21/20 Fly Intel: Pre-market Movers NVAX Novavax $201.33 / -39 (-16.23%) 09:00 Today Fly Intel: Pre-market Movers 03/01/21 Fly Intel: After-Hours Movers 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 04/09/21 Pharma/Biopharma 00:00 Today 41st Annual Healthcare Virtual Conference 00:00 Today 42nd Annual Institutional Investors Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 09:00 Today Target - TGT 09:00 Today Kohl's - KSS 09:00 Today Amyris - AMRS 04/20/21 Johnson & Johnson - JNJ 04/29/21 Merck - MRK 03/20/21 PDUFA Date for Roxadustat--Extended Date 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) 09:00 Today Target Corporation 03/08/21 Perion Network Ltd. TGT KSS JNJ MRK ZM AMRS FGEN NVAX TGT Target $177.29 / -8.83 (-4.74%) 09:55 Today Early notable gainers among liquid option names on March 2nd 09:40 Today Unusually active option classes on open March 2nd 11/19/20 Early notable gainers among liquid option names on November 19th 11/17/20 Unusually active option classes on open November 17th KSS Kohl's $58.35 / +1.4 (+2.46%) 01/11/21 Early notable gainers among liquid option names on January 11th 12/30/20 Early notable gainers among liquid option names on December 30th 12/18/20 Early notable gainers among liquid option names on December 18th 12/11/20 Kohl's put volume heavy and directionally bearish JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th MRK Merck $73.20 / +0.83 (+1.15%) 09:40 Today Unusually active option classes on open March 2nd 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish ZM Zoom Video $401.54 / -8.125 (-1.98%) 03/01/21 Zoom Video Communications options imply 15.8% move in share price post-earnings 02/05/21 Zoom Video Communications call volume above normal and directionally bullish 01/15/21 Zoom Video Communications call volume above normal and directionally bullish 01/12/21 Zoom Video Communications call volume above normal and directionally bullish AMRS Amyris $20.46 / +4.84 (+30.99%) 01/04/21 Amyris call volume above normal and directionally bullish 12/30/20 Amyris call volume above normal and directionally bullish 12/28/20 Amyris call volume above normal and directionally bullish 12/24/20 Unusual call flow in option market yesterday FGEN FibroGen $35.50 / -14.76 (-29.37%) 10/12/20 Unusually active option classes on open October 12th NVAX Novavax $201.33 / -39 (-16.23%) 03/01/21 Novavax options imply 15.7% move in share price post-earnings 02/22/21 Million dollar long-shot call spread buyer in Noravax will cross earnings 11/27/20 Unusually active option classes on open November 27th 11/13/20 Novavax call volume above normal and directionally bullish
Options	General Motors call volume above normal and directionally bullish » 12:25 03/02/21 03/02 12:25 03/02/21 12:25 GM General Motors $54.01 / +1.425 (+2.71%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GM General Motors $54.01 / +1.425 (+2.71%) 02/25/21 Caterpillar elects Gerald Johnson to board of directors 02/17/21 EU passenger car registrations down 24.0% in January 02/16/21 Berkshire Hathaway buys Verizon, exits Barrick Gold in Q4 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 GM General Motors $54.01 / +1.425 (+2.71%) 02/19/21 Morgan Stanley GM's 'hidden gems' drawing rising investor interest, says Morgan Stanley 02/18/21 Citi General Motors price target raised to $85 from $70 at Citi 02/16/21 Wedbush Wedbush expects Apple to announce formal EV partnership in 2021 02/11/21 RBC Capital General Motors price target raised to $67 from $52 at RBC Capital GM General Motors $54.01 / +1.425 (+2.71%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B GM General Motors $54.01 / +1.425 (+2.71%) 02/26/21 GM to furlough workers at Brazil plant for at least 20 days, Reuters reports 02/24/21 GM CFO believes worst of global chip shortage is over, CNBC reports 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/02/21 'Apple Car' to use E-GMP platform from Hyundai, Apple Insider reports GM General Motors $54.01 / +1.425 (+2.71%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 03/05/21 General Motors - GM GM General Motors $54.01 / +1.425 (+2.71%) 01/28/21 General Motors call volume above normal and directionally bullish 01/20/21 Notable open interest changes for January 20th 01/19/21 Early notable gainers among liquid option names on January 19th 01/13/21 Early notable gainers among liquid option names on January 13th
Conference/Events	Jefferies software/Internet analyst to hold analyst/industry conference call » 12:25 03/02/21 03/02 12:25 03/02/21 12:25 SNOW Snowflake $272.50 / +0.63 (+0.23%) Software & Internet… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SNOW Snowflake $272.50 / +0.63 (+0.23%) 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/10/21 Jennison Associates reports 7.2% passive stake in Snowflake 01/27/21 Infosys becomes 'elite' service partner with Snowflake 01/14/21 Snowflake announces partnership with Saturn Cloud for '100x faster' data science SNOW Snowflake $272.50 / +0.63 (+0.23%) 01/21/21 Goldman Sachs Snowflake initiated with a Neutral at Goldman Sachs 01/19/21 Rosenblatt Snowflake initiated with a Neutral at Rosenblatt 01/15/21 Credit Suisse Snowflake price target raised to $310 from $265 at Credit Suisse 01/13/21 Citi Snowflake price target raised to $325 from $300 at Citi SNOW Snowflake $272.50 / +0.63 (+0.23%) 12/02/20 Snowflake sees Q4 GAAP product revenue up 97%-103% from last year at $162M-$167M 12/02/20 Snowflake reports Q3 EPS ($1.01), consensus (26c) 12/02/20 Notable companies reporting after market close 16 Sep SNOW Snowflake $272.50 / +0.63 (+0.23%) 09/26/20 Western Digital could have plenty of upside, Barron's says 09/15/20 Snowflake IPO priced at $120 per share, CNBC reports SNOW Snowflake $272.50 / +0.63 (+0.23%) 01/13/21 Citi says sell Palantir on deceleration in growth, upcoming lockup expiry 01/03/21 Opening Day: Six IPOs to watch in 2021 12/15/20 Before the Move: Watch Snowflake into lockup expiration 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street 13:00 Today Software & Internet 03/03/21 Snowflake - SNOW 03/11/21 Snowflake - SNOW SNOW Snowflake $272.50 / +0.63 (+0.23%) 02/09/21 Snowflake call volume above normal and directionally bullish 02/03/21 Unusually active option classes on open February 3rd 01/07/21 Snowflake call volume above normal and directionally bullish 12/15/20 Unusually active option classes on open December 15th
Conference/Events	Jefferies consumer goods analyst to hold analyst/industry conference call » 12:25 03/02/21 03/02 12:25 03/02/21 12:25 Consumer Goods Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	CAE price target raised to C$41 from C$34 at National Bank » 12:24 03/02/21 03/02 12:24 03/02/21 12:24 CAE CAE $29.22 / -0.73 (-2.44%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CAE CAE $29.22 / -0.73 (-2.44%) 03/01/21 CAE to acquire L3Harris Technologies military training business for $1.05B 03/01/21 L3Harris Technologies to sell Military Training, Combat Propulsion for $1.45B 02/12/21 CAE sees 2021 CapEx $100M 02/02/21 CAE signs contract with Pyure to assemble anti-COVID-19 air sanitizers CAE CAE $29.22 / -0.73 (-2.44%) 10:59 Today TD Securities CAE price target raised to C$40 from C$34 at TD Securities 02/16/21 TD Securities CAE price target raised to C$34 from C$33 at TD Securities 02/16/21 Scotiabank CAE price target raised to C$39 from C$38 at Scotiabank 02/16/21 Canaccord CAE price target raised to C$34 from C$32 at Canaccord CAE CAE $29.22 / -0.73 (-2.44%) 02/12/21 CAE reports Q3 EPS ex-items C$0.22 vs. C$0.37 a year ago 11/10/20 CAE reports Q2 EPS C$0.13 vs. C$0.28 a year ago CAE CAE $29.22 / -0.73 (-2.44%) 02/28/21 CAE near deal to acquire L3Harris military-training unit, WSJ reports CAE CAE $29.22 / -0.73 (-2.44%) 11/16/20 Fly Intel: After-Hours Movers 05/19/21 CAE - CAE

Recommendations	Park Lawn price target raised to C$40 from C$33.50 at National Bank » 12:23 03/02/21 03/02 12:23 03/02/21 12:23 PRRWF Park Lawn $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PRRWF Park Lawn $0.00 / + (+0.00%) 02/17/21 Stifel Park Lawn price target raised to C$40.25 from C$35.50 at Stifel 12/16/20 National Bank Park Lawn price target lowered to C$33.50 from C$35.50 at National Bank 11/30/20 RBC Capital Park Lawn initiated with an Outperform at RBC Capital 11/16/20 National Bank Park Lawn price target raised to C$35.50 from C$35 at National Bank
Conference/Events	UBS derivatives analyst to hold an analyst/industry conference call » 12:19 03/02/21 03/02 12:19 03/02/21 12:19 Head of Americas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Technical Analysis	NASDAQ market internals summary » 12:17 03/02/21 03/02 12:17 03/02/21 12:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 03/01/21 NASDAQ market internals summary 03/01/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 12:16 03/02/21 03/02 12:16 03/02/21 12:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 03/01/21 NYSE market internals summary 03/01/21 NYSE market internals summary
General news	Treasury Action: Treasury yields are being tugged lower » 12:10 03/02/21 03/02 12:10 03/02/21 12:10 Treasury Action: Treasury… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Hot Stocks	Epizyme expects cash to fund initiatives into 2023 » 12:07 03/02/21 03/02 12:07 03/02/21 12:07 EPZM Epizyme $9.65 / -0.13 (-1.33%) The company reiterated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:06 Today Epizyme plans to submit IND application for SETD2 in mid-2021 12:05 Today Epizyme to initiate basket trials in additional heme, solid tumors in 2H21 12:04 Today Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Periodicals	Xpeng to offer cheaper battery option for P7 model in China, SCMP reports » 12:06 03/02/21 03/02 12:06 03/02/21 12:06 XPEV Xpeng $32.59 / -2.905 (-8.18%) , TSLA Tesla $704.20 / -14.53 (-2.02%) Xpeng (XPEV), which is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 05:41 Today Xpeng delivers 2.223 Smart EVs in February 02/22/21 Xpeng guided pilot function used for over 1M kilometers since launch 02/01/21 Xpeng delivers 6,015 Smart EVs in January, up 470% 01/26/21 Xpeng announces 'major over-the-air upgrade' for P7 sedan owners in China TSLA Tesla $704.20 / -14.53 (-2.02%) 02/17/21 Cathie Wood says ARK adding to positions in Tesla 02/17/21 EU passenger car registrations down 24.0% in January 02/11/21 EVgo extends nation's largest fast charging network to Tesla drivers 02/10/21 Tesla director Kimbal Musk sells $25.6M in common stock XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 01/28/21 Morgan Stanley starts Xpeng at Overweight on in-house R&D, market potential 01/28/21 Morgan Stanley Xpeng initiated with an Overweight at Morgan Stanley 01/21/21 Deutsche Bank Deutsche puts short-term buy on Xpeng ahead of 'several catalysts' 01/21/21 Deutsche Bank Xpeng named 'Catalyst Call: Buy Idea' at Deutsche Bank TSLA Tesla $704.20 / -14.53 (-2.02%) 02/25/21 Wedbush Wedbush sees limited impact to Tesla from chip-driven factory shutdowns 02/22/21 Wedbush Wedbush estimates Tesla made roughly $1B on bitcoin investment 02/22/21 Argus Livent upgraded to Buy from Hold at Argus 02/16/21 Wedbush India factory 'a smart strategic move' by Tesla, says Wedbush XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 11/12/20 Xpeng sees Q4 revenue RMB 2.2B, up 244% year-over-year 11/12/20 Xpeng reports Q3 EPS (32c), deliveries of 8,578 TSLA Tesla $704.20 / -14.53 (-2.02%) 01/27/21 Tesla reports Q4 non-GAAP EPS 80c, consensus $1.01 01/27/21 Notable companies reporting after market close 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 09 Dec 27 Aug XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 12/12/20 Nio, Xeng, Li Auto not the next Tesla, Barron's says 12/02/20 House approves bill restricting Chinese firms on U.S exchanges, Bloomberg says 12/01/20 Lucid Motors finishes 1st part of construction on Arizona factory, Electrek says TSLA Tesla $704.20 / -14.53 (-2.02%) 06:20 Today Tesla still relying on supply outside China for Gigafactory 3, DigiTimes reports 02/25/21 Tesla to temporarily halt Model 3 line at California plant, Bloomberg reports 02/23/21 Lucid CEO tells Bloomberg production delay due to Churchill concerns 02/22/21 Tesla stops taking order for base Model Y SUV, Electrek reports XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 02/06/21 Charged: Apple, Hyundai-Kia said to be close to 'Apple Car' deal 02/01/21 Piper more than doubles Tesla target as EV competitors report delivery numbers 02/01/21 Fly Intel: Pre-market Movers 01/28/21 Fly Intel: After-Hours Movers TSLA Tesla $704.20 / -14.53 (-2.02%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/23/21 SPACs slide after Lucid Motors confirms anticipated come-public deal 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 03/08/21 Xpeng - XPEV XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 02/10/21 XPeng call volume above normal and directionally bullish 01/22/21 XPeng call volume above normal and directionally bullish 01/19/21 XPeng call volume above normal and directionally bullish 01/12/21 XPeng call volume above normal and directionally bullish TSLA Tesla $704.20 / -14.53 (-2.02%) 02/24/21 Notable open interest changes for February 24th 02/23/21 Notable open interest changes for February 23rd 02/22/21 Notable open interest changes for February 22nd 02/11/21 Notable open interest changes for February 11th
Hot Stocks	Epizyme plans to submit IND application for SETD2 in mid-2021 » 12:06 03/02/21 03/02 12:06 03/02/21 12:06 EPZM Epizyme $9.65 / -0.13 (-1.33%) SETD2 is a histone… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:05 Today Epizyme to initiate basket trials in additional heme, solid tumors in 2H21 12:04 Today Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Hot Stocks	Epizyme to initiate basket trials in additional heme, solid tumors in 2H21 » 12:05 03/02/21 03/02 12:05 03/02/21 12:05 EPZM Epizyme $9.65 / -0.13 (-1.33%) Epizyme will initiate two… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:04 Today Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Options	Digital Turbine call volume above normal and directionally bullish » 12:05 03/02/21 03/02 12:05 03/02/21 12:05 APPS Digital Turbine $94.58 / -0.19 (-0.20%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/26/21 Digital Turbine to acquire AdColony for $350M-$375M 02/26/21 Digital Turbine to acquire AdColony from Otello Corp for $400M consideration 09/09/20 Digital Turbine CEO Stone sells 84,585 common shares APPS Digital Turbine $94.58 / -0.19 (-0.20%) 03/01/21 Craig-Hallum Digital Turbine price target raised to $90 from $80 at Craig-Hallum 03/01/21 Roth Capital Digital Turbine price target raised to $100 from $87 at Roth Capital 02/04/21 Craig-Hallum Digital Turbine price target raised to $80 from $60 at Craig-Hallum 02/04/21 Roth Capital Digital Turbine price target raised to $87 from $70 at Roth Capital APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/03/21 Digital Turbine sees FY21 adjusted EPS 67c, consensus 63c 02/03/21 Digital Turbine reports Q3 adjusted EPS 21c, consensus 17c 10/29/20 Digital Turbine sees Q3 non-GAAP EPS 15c-16c, consensus 12c 10/29/20 Digital Turbine sees Q3 non-GAAP EPS 15c-16c, consensus 12c APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/04/21 Fly Intel: Wall Street's top stories for Thursday 02/04/21 Fly Intel: Wall Street's top stories at midday APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/23/21 Digital Turbine call volume above normal and directionally bullish 02/03/21 Digital Turbine options imply 17.0% move in share price post-earnings 11/18/20 Unusually active option classes on open November 18th 11/05/20 Digital Turbine call volume above normal and directionally bullish

Hot Stocks	Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 » 12:04 03/02/21 03/02 12:04 03/02/21 12:04 EPZM Epizyme $9.65 / -0.13 (-1.33%) The combination of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement 11/06/20 Epizyme sees funds sufficient into at least 2023 EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Hot Stocks	Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 » 12:04 03/02/21 03/02 12:04 03/02/21 12:04 EPZM Epizyme $9.65 / -0.13 (-1.33%) The combination of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement 11/06/20 Epizyme sees funds sufficient into at least 2023 10/07/20 Epizyme's Tazverik Phase 2 data featured in two Lancet Oncology publications EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Conference/Events	Net 1 UEPS participates in a conference call hosted by B. Riley Securities » 12:02 03/02/21 03/02 12:02 03/02/21 12:02 UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) 02/09/21 Net 1 UEPS appoints Lincoln Mali as South African CEO 02/04/21 Net 1 UEPS sells remaining interest in Bank Frick for $30M UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) 01/20/21 B. Riley Securities Net 1 UEPS price target raised to $7 from $5 at B. Riley Securities 09/15/20 B. Riley FBR Net 1 UEPS 'stands out as significantly undervalued,' says B. Riley FBR 09/08/20 B. Riley FBR Net 1 UEPS transferred with Buy rating, $5 target at B. Riley FBR UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) 12/21/20 Fly Insider: Net 1 UEPS, GrafTech among weeks notable insider trades 11/30/20 Fly Insider: Merrimack, Catalent among weeks notable insider trades 10/05/20 Fly Insider: Odonate Therapeutics, Carvana among week's notable insider trades 00:00 Today Net 1 UEPS - UEPS
Hot Stocks	CNH Industrial completes minority investment in Monarch Tractor » 12:02 03/02/21 03/02 12:02 03/02/21 12:02 CNHI CNH Industrial $14.91 / -0.13 (-0.86%) CNH Industrial announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CNHI CNH Industrial $14.91 / -0.13 (-0.86%) 02/24/21 EU commercial vehicle registrations down 7.2% in January 01/26/21 EU commercial vehicle registrations down 4.2% in December 11/30/20 Accenture, Microsoft collaborate with CNH Industrial on connected vehicles 11/25/20 EU commercial vehicle registrations down 1.2% in October CNHI CNH Industrial $14.91 / -0.13 (-0.86%) 02/18/21 Citi CNH Industrial resumed with a Buy at Citi 02/04/21 Vertical Research CNH Industrial upgraded to Buy from Hold at Vertical Research 01/20/21 Vertical Research CNH Industrial initiated with a Hold at Vertical Research 12/15/20 Stifel CNH Industrial price target raised to $12 from $9.50 at Stifel CNHI CNH Industrial $14.91 / -0.13 (-0.86%) 02/03/21 CNH Industrial reports Q4 adjusted EPS 30c, consensus 14c 11/05/20 CNH Industrial reports Q3 adjusted EPS 11c, consensus 2c
Conference/Events	Alpha & Omega participates in a conference call hosted by B. Riley Securities » 12:01 03/02/21 03/02 12:01 03/02/21 12:01 AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 11/13/20 Alpha & Omega announces retirement of COO Dr. Yueh-se Ho AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 02/10/21 B. Riley Securities B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion 02/08/21 Loop Capital Alpha & Omega price target raised to $45 from $35 at Loop Capital 02/05/21 B. Riley Securities Alpha & Omega price target raised to $44 from $40 at B. Riley Securities 01/25/21 B. Riley Securities Alpha & Omega price target raised to $40 from $35 at B. Riley Securities AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 02/04/21 Alpha & Omega sees Q3 revenue approximately $157M plus or minus $3M 02/04/21 Alpha & Omega reports Q2 adjusted EPS 65c, consensus 54c 11/05/20 Alpha & Omega sees Q2 revenue $150M-$156M, consensus $141.4M. 11/05/20 Alpha & Omega reports Q1 EPS 55c, consensus 51c AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 02/04/21 Fly Intel: After-Hours Movers 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 00:00 Today Alpha & Omega - AOSL

Conference/Events	Progressive to host investor conference call » 12:01 03/02/21 03/02 12:01 03/02/21 12:01 PGR Progressive $88.50 / +0.88 (+1.00%) Management hosts a 4th… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PGR Progressive $88.50 / +0.88 (+1.00%) 02/16/21 Progressive to acquire Protective Insurance for $23.30 per share in cash PGR Progressive $88.50 / +0.88 (+1.00%) 02/01/21 Deutsche Bank Progressive price target lowered to $105 from $108 at Deutsche Bank 01/13/21 Gordon Haskett Allstate lowering auto rates by 5% in several states, says Gordon Haskett 01/08/21 Goldman Sachs Progressive downgraded to Sell from Neutral at Goldman Sachs 01/07/21 B. Riley Securities Progressive price target raised to $96 from $88 at B. Riley Securities PGR Progressive $88.50 / +0.88 (+1.00%) 02/17/21 Progressive reports January EPS 95c vs. 52c last year 01/27/21 Progressive reports December EPS $1.20 vs. 78c last year 01/27/21 Progressive reports Q4 EPS $2.85, consensus $1.66 01/26/21 Notable companies reporting before tomorrow's open PGR Progressive $88.50 / +0.88 (+1.00%) 09/22/20 Amazon upgrade, PayPal initiation among today's top calls on Wall Street 13:00 Today Progressive - PGR 13:00 Today Progressive Corporation PGR Progressive $88.50 / +0.88 (+1.00%) 12/07/20 Early notable gainers among liquid option names on December 7th
Hot Stocks	C3.ai falls -14.0% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 AI C3.ai $104.12 / -16.66 (-13.79%) C3.ai is down -14.0%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options AI C3.ai $104.12 / -16.66 (-13.79%) 10:01 Today C3.ai falls -12.6% 09:47 Today C3.ai falls -11.9% 02/25/21 C3.ai awarded omnibus U.S. patent for end-to-end enterprise AI platform 02/01/21 Shell, C3, Baker Hughes, Microsoft launch Open AI Energy Initiative AI C3.ai $104.12 / -16.66 (-13.79%) 07:31 Today Canaccord C3.ai price target lowered to $120 from $140 at Canaccord 01/04/21 KeyBanc C3.ai initiated with a Sector Weight at KeyBanc 01/04/21 Wedbush Wedbush bullish on C3.ai, initiates with an Outperform 01/04/21 Canaccord C3.ai initiated with a Hold at Canaccord AI C3.ai $104.12 / -16.66 (-13.79%) 03/01/21 C3.ai reports Q3 EPS (13c), consensus (16c) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 09 Dec AI C3.ai $104.12 / -16.66 (-13.79%) 03/01/21 Fly Intel: After-Hours Movers 01/04/21 Fly Intel: Pre-market Movers 12/13/20 Opening Day: Airbnb shares double in IPO, DoorDash soars in debut 09/23/20 Fly Intel: After-Hours Movers 00:00 Today Energy & Power Virtual Conference AI C3.ai $104.12 / -16.66 (-13.79%) 02/09/21 C3 AI call volume above normal and directionally bullish 02/02/21 C3 AI call volume above normal and directionally bullish 01/06/21 Largest borrow rate increases among liquid names 12/15/20 Two new option listings on December 15th
Hot Stocks	Switch falls -14.2% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 SWCH Switch $15.17 / -2.52 (-14.25%) Switch is down -14.2%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SWCH Switch $15.17 / -2.52 (-14.25%) 10:02 Today Switch falls -10.7% 09:47 Today Switch falls -11.3% 03/01/21 Switch drops about 7% to $16.51 after reporting mixed Q4 results 09/16/20 Switch appoints Angela Archon to Board of Directors, effective November 4 SWCH Switch $15.17 / -2.52 (-14.25%) 08:21 Today Raymond James Switch downgraded to Outperform from Strong Buy at Raymond James 04:44 Today Raymond James Switch downgraded to Outperform from Strong Buy at Raymond James 02/02/21 Truist sees Switch positioned for long-term growth, starts at Buy 02/02/21 Truist Switch initiated with a Buy at Truist SWCH Switch $15.17 / -2.52 (-14.25%) 03/01/21 Switch sees FY21 revenue $540M-$555M, consensus $588.3M 03/01/21 Switch reports Q4 adjusted EPS 6c, consensus 5c 11/05/20 Switch sees FY20 revenue $510M-$518M, consensus $516.47M 11/05/20 Switch reports Q3 EPS 5c, consensus 4c SWCH Switch $15.17 / -2.52 (-14.25%) 03/01/21 Fly Intel: After-Hours Movers
Hot Stocks	3D Systems falls -14.8% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 DDD 3D Systems $33.05 / -5.69 (-14.69%) 3D Systems is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DDD 3D Systems $33.05 / -5.69 (-14.69%) 03/01/21 3D Systems sees FY21 gross margin 40%-44% 02/24/21 3D Systems announces introduction of High Speed Fusion 3D printing system 02/11/21 3D Systems selected by Raytheon and DEVCOM as part of research project 02/03/21 3D Systems rises 16.2% DDD 3D Systems $33.05 / -5.69 (-14.69%) 01/29/21 Craig-Hallum 3D Systems downgraded to Hold from Buy at Craig-Hallum 01/29/21 Craig-Hallum 3D Systems downgraded to Hold from Buy at Craig-Hallum 01/25/21 Fly Intel: Top five analyst downgrades 01/25/21 Berenberg 3D Systems downgraded to Hold from Buy at Berenberg DDD 3D Systems $33.05 / -5.69 (-14.69%) 03/01/21 3D Systems reports Q4 EPS 9c, consensus 10c 03/01/21 Notable companies reporting after market close 01/07/21 3D Systems sees Q4 revenue $170M-$176M, consensus $139.91M. 11/05/20 3D Systems reports Q3 EPS (3c), consensus (8c) DDD 3D Systems $33.05 / -5.69 (-14.69%) 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street 01/15/21 Fly Intel: Pre-market Movers 01/07/21 Fly Intel: Wall Street's top stories for Thursday 01/07/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Industrial Technologies Virtual Conference 2021 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 08:30 Today 3D Systems - DDD DDD 3D Systems $33.05 / -5.69 (-14.69%) 01/14/21 3D Systems call volume above normal and directionally bullish 01/07/21 3D Systems call volume above normal and directionally bullish 12/29/20 3D Systems put volume heavy and directionally bearish 12/17/20 3D Systems call volume above normal and directionally bullish
Hot Stocks	Fisker rises 15.0% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 FSR Fisker $31.68 / +4.32 (+15.79%) Fisker is up 15.0%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FSR Fisker $31.68 / +4.32 (+15.79%) 03/01/21 Fisker CEO tweets about passing 13,000 Ocean reservations 'fast!' 03/01/21 Fisker falls -9.3% 02/25/21 Fisker up 6% to $22.86 after Q4 report 02/25/21 Fisker sees FY21 operating expenses $210M-$240M FSR Fisker $31.68 / +4.32 (+15.79%) 02/26/21 Morgan Stanley Fisker price target raised to $40 from $27 at Morgan Stanley 02/26/21 Cowen Fisker price target raised to $29 from $22 at Cowen 02/17/21 R.F. Lafferty Fisker initiated with a Buy at R.F. Lafferty 02/11/21 Morgan Stanley Fisker initiated with an Overweight at Morgan Stanley FSR Fisker $31.68 / +4.32 (+15.79%) 02/25/21 Fisker reports Q4 EPS (5c), consensus (5c) 02/25/21 Notable companies reporting after market close FSR Fisker $31.68 / +4.32 (+15.79%) 02/16/21 Churchill Capital soars after Reuters says deal with Lucid Motors is close 02/16/21 Churchill Capital Corp IV near deal to bring Lucid Motors public, Reuters says 01/26/21 Fisker rallies after Seeking Alpha contributor sees 1,000% long-term upside FSR Fisker $31.68 / +4.32 (+15.79%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/25/21 Fly Intel: After-Hours Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday FSR Fisker $31.68 / +4.32 (+15.79%) 10:25 Today Fisker call volume above normal and directionally bullish 02/26/21 Fisker call volume above normal and directionally bullish 02/24/21 Fisker call volume above normal and directionally bullish 02/12/21 Fisker call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

PS
Today at 12:30

Pluralsight, Inc. Firm Sponsored Meetings
Today at 13:00

Fed Governor Speaks on US Economic Outlook Government Event

Virtual Evemt
PGR
Today at 13:00

Progressive - PGR Conference Calls
WORK
Today at 13:00

Slack Technologies, Inc. Firm Sponsored Meetings
PGR
Today at 13:00

Progressive Corporation Firm Sponsored Meetings

Virtual Meeting
Today at 13:00

Consumer Goods Industry Meetings
SNOW
Today at 13:00

Software & Internet Industry Meetings
Today at 14:00

Fed Reserve Bank of San Francisco President Speaks Government Event

Virtual Evemt
CCOI
Today at 14:00

Cogent - CCOI Conference Calls
Today at 14:00

Technology Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $36.00-38.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Evolus price target raised to $8 from $4 at Barclays

TODAY'S FREE FLY STORIES

Get Full Fly Access